Patents-Review.com
ClassID:

116231 ⎘

C12Y301/01064 - CPC Classification

Classification description:

Hydrolases acting on ester bonds (3.1); Carboxylic ester hydrolases (3.1.1) Retinoid isomerohydrolase (3.1.1.64)

Recent Application in this class:
#1
20250305024
2025-10-02

RELATIVE POTENCY ASSAY FOR VIRAL VECTOR ENCODING ISOMEROHYDROLASES

 #2
20250295808
2025-09-25

A SYSTEM FOR AN OCULAR GENE THERAPY AND A PROCESS FOR PREPARING THEREOF

 #3
20240293580
2024-09-05

Optimized RPE65 Promoter and Coding Sequences

 #4
20230321280
2023-10-12

COMPOSITIONS AND METHODS FOR THE TREATMENT OF OCULAR DISEASES

 #5
20220267777
2022-08-25

DIFFERENTIAL KNOCKOUT OF A HETEROZYGOUS ALLELE OF RPE65

 #6
20210348210
2021-11-11

RELATIVE POTENCY ASSAY FOR VIRAL VECTOR ENCODING ISOMEROHYDROLASES

 #7
20210324343
2021-10-21

RECOMBINANT ADENO-ASSOCIATED VIRUS PARTICLE PURIFICATION COMPRISING AN AFFINITY PURIFICATION STEP

 #8
20210254037
2021-08-19

PHARMACEUTICAL COMPOSITION COMPRISING FUSION PROTEIN OF CELL-PENETRATING PEPTIDE AND RPE65 FOR TREATMENT OF LEBER'S CONGENITAL AMAUROSIS

 #9
20210000972
2021-01-07

NANOPARTICLES FOR SUSTAINED OPHTHALMIC DRUG DELIVERY AND METHODS OF USE

 #10
20200405845
2020-12-31

Scalable manufacturing platform for viral vector purification and viral vectors so purified for use in gene therapy

 #11
20200179535
2020-06-11

Optimized RPE65 promoter and coding sequences

 #12
20190382733
2019-12-19

Recombinant adeno-associated virus particle purification comprising an affinity purification step

 #13
20190321463
2019-10-24

SCALABLE MANUFACTURING PLATFORM FOR VIRAL VECTOR PURIFICATION AND VIRAL VECTORS SO PURIFIED FOR USE IN GENE THERAPY

 #14
20180207293
2018-07-26

NANOPARTICLES FOR SUSTAINED OPHTHALMIC DRUG DELIVERY AND METHODS OF USE

 #15
20180021458
2018-01-25

Optimized RPE65 promoter and coding sequences

 #16
20170226490
2017-08-10

High isomerohydrolase activity mutants of human RPE65

 #17
20170014529
2017-01-19

Method of Treating or Retarding the Development of Blindness

 #18
20160206706
2016-07-21

Scalable manufacturing platform for viral vector purification and viral vectors so purified for use in gene therapy

 #19
20120225930
2012-09-06

METHOD OF TREATING OR RETARDING THE DEVELOPMENT OF BLINDNESS

 #20
20100272688
2010-10-28

Method of treating or retarding the development of blindness

 #21
20090074723
2009-03-19

Method of Treating or Retarding the Development of Blindness

 #22
20070077228
2007-04-05

Method of treating or retarding the development of blindness